{"transactions":[{"id":1534547,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2024-04-26T20:03:56.000Z","date":"2023-07-01","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is being filed late due to an administrative error."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units granted to Mr. Tutewohl pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. On July 31, 2023, Mr. Tutewohl's last day of employment with the company, 3,000 of these RSUs vested and the remaining 6,000 were forfeited, in accordance with the terms of Mr. Tutewohl's severance and change in control agreement. Mr. Tutewohl ceased to be an officer of the company on July 3, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":136331,"source":{"system":"sec-edgar","filing":"0001628908-24-000044","document":"wk-form4_1714161825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000044/wk-form4_1714161825.xml","form_type":"4"}},{"id":1971520,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-03T22:42:35.000Z","date":"2023-03-02","kind":"tax_withholding","acquired":false,"shares":3200,"price":35.15,"value":112480.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":127331,"source":{"system":"sec-edgar","filing":"0001628908-23-000041","document":"wf-form4_167788327939137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000041/wf-form4_167788327939137.xml","form_type":"4"}},{"id":1971519,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-03T22:42:35.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":2176,"price":35.26,"value":76725.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":130531,"source":{"system":"sec-edgar","filing":"0001628908-23-000041","document":"wf-form4_167788327939137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000041/wf-form4_167788327939137.xml","form_type":"4"}},{"id":1971518,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-03T22:42:35.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":17011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Tutewohl pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 34% on March 1, 2024, and 33% on March 1, 2025, and March 1, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":132707,"source":{"system":"sec-edgar","filing":"0001628908-23-000041","document":"wf-form4_167788327939137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000041/wf-form4_167788327939137.xml","form_type":"4"}},{"id":1995266,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-24T00:10:39.000Z","date":"2023-02-21","kind":"tax_withholding","acquired":false,"shares":4774,"price":28.08,"value":134053.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of PSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":115696,"source":{"system":"sec-edgar","filing":"0001628908-23-000021","document":"wf-form4_167719742371751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000021/wf-form4_167719742371751.xml","form_type":"4"}},{"id":1995265,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-24T00:10:39.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":14300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares received upon the settlement of the first tranche of performance-based share units (PSUs) awarded to the reporting person on March 1, 2021, following the certification of achievement of specified performance metrics. The shares underlying the first tranche of the PSU award vested at the conclusion of the performance period on December 31, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":120470,"source":{"system":"sec-edgar","filing":"0001628908-23-000021","document":"wf-form4_167719742371751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000021/wf-form4_167719742371751.xml","form_type":"4"}},{"id":2213915,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-05T23:20:20.000Z","date":"2022-07-01","kind":"tax_withholding","acquired":false,"shares":2251,"price":31.12,"value":70051.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":106170,"source":{"system":"sec-edgar","filing":"0001628908-22-000090","document":"wf-form4_165706320470171.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000090/wf-form4_165706320470171.xml","form_type":"4"}},{"id":2347046,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-07T22:09:08.000Z","date":"2022-03-03","kind":"sale","acquired":false,"shares":1918,"price":27.3,"value":52361.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.04 to $27.78, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":108421,"source":{"system":"sec-edgar","filing":"0001628908-22-000052","document":"wf-form4_164669093397916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000052/wf-form4_164669093397916.xml","form_type":"4"}},{"id":2349557,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-05T02:04:28.000Z","date":"2022-03-02","kind":"tax_withholding","acquired":false,"shares":4499,"price":27.54,"value":123902.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":110339,"source":{"system":"sec-edgar","filing":"0001628908-22-000047","document":"wf-form4_164644584510521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000047/wf-form4_164644584510521.xml","form_type":"4"}},{"id":2352638,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2022-03-04T02:15:42.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":5388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Class A Common Stock Options exercised vested on March 1, 2022."}],"balance_after":5388,"derivative":{"exercise_price":13.29,"expiration_date":"2029-03-01","underlying":"Class A Common Stock","underlying_shares":5388},"source":{"system":"sec-edgar","filing":"0001628908-22-000029","document":"wf-form4_164636012529223.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000029/wf-form4_164636012529223.xml","form_type":"4"}},{"id":2352637,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:15:42.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":5388,"price":27.41,"value":147685.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.71 to $28.02, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":114838,"source":{"system":"sec-edgar","filing":"0001628908-22-000029","document":"wf-form4_164636012529223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000029/wf-form4_164636012529223.xml","form_type":"4"}},{"id":2352636,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:15:42.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":5388,"price":13.29,"value":71606.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":121130,"source":{"system":"sec-edgar","filing":"0001628908-22-000029","document":"wf-form4_164636012529223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000029/wf-form4_164636012529223.xml","form_type":"4"}},{"id":2352635,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:15:42.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":4005,"price":27.4,"value":109737.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":114838,"source":{"system":"sec-edgar","filing":"0001628908-22-000029","document":"wf-form4_164636012529223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000029/wf-form4_164636012529223.xml","form_type":"4"}},{"id":2352634,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:15:42.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Tutewohl pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 34% on March 1, 2023, and 33 % on March 1, 2024, and March 1, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":118843,"source":{"system":"sec-edgar","filing":"0001628908-22-000029","document":"wf-form4_164636012529223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000029/wf-form4_164636012529223.xml","form_type":"4"}},{"id":2409803,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-07T22:05:55.000Z","date":"2022-02-03","kind":"sale","acquired":false,"shares":1707,"price":22.85,"value":39004.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.39 to $23.61, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":98843,"source":{"system":"sec-edgar","filing":"0001628908-22-000009","document":"wf-form4_164427153879648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000009/wf-form4_164427153879648.xml","form_type":"4"}},{"id":2418798,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2022-02-01T22:40:39.000Z","date":"2022-02-01","kind":"exercise","acquired":false,"shares":6313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class A Common Stock Options exercised vested on February 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":13.95,"expiration_date":"2028-02-01","underlying":"Class A Common Stock","underlying_shares":6313},"source":{"system":"sec-edgar","filing":"0001628908-22-000007","document":"wf-form4_164375522107258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000007/wf-form4_164375522107258.xml","form_type":"4"}},{"id":2418797,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-01T22:40:39.000Z","date":"2022-02-01","kind":"sale","acquired":false,"shares":6313,"price":23.47,"value":148166.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.80, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":100550,"source":{"system":"sec-edgar","filing":"0001628908-22-000007","document":"wf-form4_164375522107258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000007/wf-form4_164375522107258.xml","form_type":"4"}},{"id":2418796,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-01T22:40:39.000Z","date":"2022-02-01","kind":"exercise","acquired":true,"shares":6313,"price":13.95,"value":88066.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":106863,"source":{"system":"sec-edgar","filing":"0001628908-22-000007","document":"wf-form4_164375522107258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000007/wf-form4_164375522107258.xml","form_type":"4"}},{"id":2580978,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-02T21:19:52.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":13553,"price":25.05,"value":339502.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.16, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":100550,"source":{"system":"sec-edgar","filing":"0001628908-21-000124","document":"wf-form4_163061757088336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000124/wf-form4_163061757088336.xml","form_type":"4"}},{"id":2614185,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2021-08-04T21:52:38.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":11229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The Class A Common Stock Options exercised vested on February 1, 2019, February 1, 2020 and February 1, 2021."}],"balance_after":0,"derivative":{"exercise_price":18.25,"expiration_date":"2027-02-01","underlying":"Class A Common Stock","underlying_shares":11229},"source":{"system":"sec-edgar","filing":"0001628908-21-000114","document":"wf-form4_162811393147458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000114/wf-form4_162811393147458.xml","form_type":"4"}},{"id":2614184,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2021-08-04T21:52:38.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":13801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The Class A Common Stock Options exercised vested on February 1, 2019, February 1, 2020 and February 1, 2021."}],"balance_after":6313,"derivative":{"exercise_price":13.95,"expiration_date":"2028-02-01","underlying":"Class A Common Stock","underlying_shares":13801},"source":{"system":"sec-edgar","filing":"0001628908-21-000114","document":"wf-form4_162811393147458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000114/wf-form4_162811393147458.xml","form_type":"4"}},{"id":2614183,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2021-08-04T21:52:38.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Class A Common Stock Options exercised vested on February 1, 2018 and February 1, 2019."}],"balance_after":11229,"derivative":{"exercise_price":18.25,"expiration_date":"2027-02-01","underlying":"Class A Common Stock","underlying_shares":2625},"source":{"system":"sec-edgar","filing":"0001628908-21-000114","document":"wf-form4_162811393147458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000114/wf-form4_162811393147458.xml","form_type":"4"}},{"id":2614182,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2021-08-04T21:52:38.000Z","date":"2021-08-02","kind":"exercise","acquired":false,"shares":3331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Class A Common Stock Options exercised vested on February 1, 2019."}],"balance_after":20114,"derivative":{"exercise_price":13.95,"expiration_date":"2028-02-01","underlying":"Class A Common Stock","underlying_shares":3331},"source":{"system":"sec-edgar","filing":"0001628908-21-000114","document":"wf-form4_162811393147458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000114/wf-form4_162811393147458.xml","form_type":"4"}},{"id":2614181,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T21:52:38.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":13801,"price":23.02,"value":317699.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.14, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":114103,"source":{"system":"sec-edgar","filing":"0001628908-21-000114","document":"wf-form4_162811393147458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000114/wf-form4_162811393147458.xml","form_type":"4"}},{"id":2614180,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T21:52:38.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":13801,"price":13.95,"value":192523.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":127904,"source":{"system":"sec-edgar","filing":"0001628908-21-000114","document":"wf-form4_162811393147458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000114/wf-form4_162811393147458.xml","form_type":"4"}},{"id":2614179,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T21:52:38.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":11229,"price":23.02,"value":258491.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ 22.99 to $23.14, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":114103,"source":{"system":"sec-edgar","filing":"0001628908-21-000114","document":"wf-form4_162811393147458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000114/wf-form4_162811393147458.xml","form_type":"4"}},{"id":2614178,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T21:52:38.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":11229,"price":18.25,"value":204929.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":125332,"source":{"system":"sec-edgar","filing":"0001628908-21-000114","document":"wf-form4_162811393147458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000114/wf-form4_162811393147458.xml","form_type":"4"}},{"id":2614177,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T21:52:38.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":2625,"price":23.02,"value":60427.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.99 to $23.13, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":114103,"source":{"system":"sec-edgar","filing":"0001628908-21-000114","document":"wf-form4_162811393147458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000114/wf-form4_162811393147458.xml","form_type":"4"}},{"id":2614176,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T21:52:38.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":2625,"price":18.25,"value":47906.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":116728,"source":{"system":"sec-edgar","filing":"0001628908-21-000114","document":"wf-form4_162811393147458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000114/wf-form4_162811393147458.xml","form_type":"4"}},{"id":2614175,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T21:52:38.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":3331,"price":23.02,"value":76679.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.13, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":114103,"source":{"system":"sec-edgar","filing":"0001628908-21-000114","document":"wf-form4_162811393147458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000114/wf-form4_162811393147458.xml","form_type":"4"}},{"id":2614174,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-04T21:52:38.000Z","date":"2021-08-02","kind":"exercise","acquired":true,"shares":3331,"price":13.95,"value":46467.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":117434,"source":{"system":"sec-edgar","filing":"0001628908-21-000114","document":"wf-form4_162811393147458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000114/wf-form4_162811393147458.xml","form_type":"4"}},{"id":2634635,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2021-07-14T01:22:00.000Z","date":"2021-07-09","kind":"exercise","acquired":false,"shares":1465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Class A Common Stock Options exercised vested on February 1, 2018."}],"balance_after":13854,"derivative":{"exercise_price":18.25,"expiration_date":"2027-02-01","underlying":"Class A Common Stock","underlying_shares":1465},"source":{"system":"sec-edgar","filing":"0001628908-21-000098","document":"wf-form4_162622569628328.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000098/wf-form4_162622569628328.xml","form_type":"4"}},{"id":2634634,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2021-07-14T01:22:00.000Z","date":"2021-07-09","kind":"exercise","acquired":false,"shares":1808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class A Common Stock Options exercised vested on February 1, 2019."}],"balance_after":23445,"derivative":{"exercise_price":13.95,"expiration_date":"2028-02-01","underlying":"Class A Common Stock","underlying_shares":1808},"source":{"system":"sec-edgar","filing":"0001628908-21-000098","document":"wf-form4_162622569628328.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000098/wf-form4_162622569628328.xml","form_type":"4"}},{"id":2634633,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2021-07-14T01:22:00.000Z","date":"2021-07-09","kind":"exercise","acquired":false,"shares":10576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class A Common Stock Options exercised vested on March 1, 2020 and March 1, 2021."}],"balance_after":10776,"derivative":{"exercise_price":13.29,"expiration_date":"2029-03-01","underlying":"Class A Common Stock","underlying_shares":10576},"source":{"system":"sec-edgar","filing":"0001628908-21-000098","document":"wf-form4_162622569628328.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000098/wf-form4_162622569628328.xml","form_type":"4"}},{"id":2634632,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-14T01:22:00.000Z","date":"2021-07-09","kind":"sale","acquired":false,"shares":1465,"price":23,"value":33695.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":114103,"source":{"system":"sec-edgar","filing":"0001628908-21-000098","document":"wf-form4_162622569628328.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000098/wf-form4_162622569628328.xml","form_type":"4"}},{"id":2634631,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-14T01:22:00.000Z","date":"2021-07-09","kind":"exercise","acquired":true,"shares":1465,"price":18.25,"value":26736.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":115568,"source":{"system":"sec-edgar","filing":"0001628908-21-000098","document":"wf-form4_162622569628328.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000098/wf-form4_162622569628328.xml","form_type":"4"}},{"id":2634630,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-14T01:22:00.000Z","date":"2021-07-09","kind":"sale","acquired":false,"shares":1808,"price":23,"value":41584.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":114103,"source":{"system":"sec-edgar","filing":"0001628908-21-000098","document":"wf-form4_162622569628328.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000098/wf-form4_162622569628328.xml","form_type":"4"}},{"id":2634629,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-14T01:22:00.000Z","date":"2021-07-09","kind":"exercise","acquired":true,"shares":1808,"price":13.95,"value":25221.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":115911,"source":{"system":"sec-edgar","filing":"0001628908-21-000098","document":"wf-form4_162622569628328.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000098/wf-form4_162622569628328.xml","form_type":"4"}},{"id":2634628,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-14T01:22:00.000Z","date":"2021-07-09","kind":"sale","acquired":false,"shares":10576,"price":22.52,"value":238171.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.25 to $22.95, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":114103,"source":{"system":"sec-edgar","filing":"0001628908-21-000098","document":"wf-form4_162622569628328.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000098/wf-form4_162622569628328.xml","form_type":"4"}},{"id":2634627,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-14T01:22:00.000Z","date":"2021-07-09","kind":"exercise","acquired":true,"shares":10576,"price":13.29,"value":140555.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":124679,"source":{"system":"sec-edgar","filing":"0001628908-21-000098","document":"wf-form4_162622569628328.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000098/wf-form4_162622569628328.xml","form_type":"4"}},{"id":2635835,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2021-07-12T20:59:53.000Z","date":"2021-07-08","kind":"exercise","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Class A Common Stock Options exercised vested on March 1, 2020."}],"balance_after":21352,"derivative":{"exercise_price":13.29,"expiration_date":"2029-03-01","underlying":"Class A Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001628908-21-000096","document":"wf-form4_162612357619668.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000096/wf-form4_162612357619668.xml","form_type":"4"}},{"id":2635834,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-12T20:59:53.000Z","date":"2021-07-08","kind":"sale","acquired":false,"shares":200,"price":22,"value":4400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":114103,"source":{"system":"sec-edgar","filing":"0001628908-21-000096","document":"wf-form4_162612357619668.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000096/wf-form4_162612357619668.xml","form_type":"4"}},{"id":2635833,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-12T20:59:53.000Z","date":"2021-07-08","kind":"exercise","acquired":true,"shares":200,"price":13.29,"value":2658.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":114303,"source":{"system":"sec-edgar","filing":"0001628908-21-000096","document":"wf-form4_162612357619668.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000096/wf-form4_162612357619668.xml","form_type":"4"}},{"id":2643571,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2021-07-02T20:37:37.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":9352,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class A Common Stock Options exercised vested on July 1, 2021."}],"balance_after":18702,"derivative":{"exercise_price":7.83,"expiration_date":"2029-07-01","underlying":"Class A Common Stock","underlying_shares":9352},"source":{"system":"sec-edgar","filing":"0001628908-21-000094","document":"wf-form4_162525821927146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000094/wf-form4_162525821927146.xml","form_type":"4"}},{"id":2643570,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-02T20:37:37.000Z","date":"2021-07-01","kind":"sale","acquired":false,"shares":9352,"price":21.05,"value":196859.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ 20.97 to $21.31, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":114103,"source":{"system":"sec-edgar","filing":"0001628908-21-000094","document":"wf-form4_162525821927146.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000094/wf-form4_162525821927146.xml","form_type":"4"}},{"id":2643569,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-02T20:37:37.000Z","date":"2021-07-01","kind":"exercise","acquired":true,"shares":9352,"price":7.83,"value":73226.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":123455,"source":{"system":"sec-edgar","filing":"0001628908-21-000094","document":"wf-form4_162525821927146.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000094/wf-form4_162525821927146.xml","form_type":"4"}},{"id":2726385,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock Option (right to buy)","published_at":"2021-05-05T22:01:50.000Z","date":"2021-05-03","kind":"exercise","acquired":false,"shares":9352,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Class A Common Stock Options exercised vested on July 1, 2020."}],"balance_after":28054,"derivative":{"exercise_price":7.83,"expiration_date":"2029-07-01","underlying":"Class A Common Stock","underlying_shares":9352},"source":{"system":"sec-edgar","filing":"0001628908-21-000051","document":"wf-form4_162025209202092.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000051/wf-form4_162025209202092.xml","form_type":"4"}},{"id":2726384,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-05-05T22:01:50.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":9352,"price":21.49,"value":200974.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.36 to $21.73, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":114103,"source":{"system":"sec-edgar","filing":"0001628908-21-000051","document":"wf-form4_162025209202092.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000051/wf-form4_162025209202092.xml","form_type":"4"}},{"id":2726383,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-05-05T22:01:50.000Z","date":"2021-05-03","kind":"exercise","acquired":true,"shares":9352,"price":7.83,"value":73226.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":123455,"source":{"system":"sec-edgar","filing":"0001628908-21-000051","document":"wf-form4_162025209202092.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000051/wf-form4_162025209202092.xml","form_type":"4"}},{"id":2726382,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-05-05T22:01:50.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":9943,"price":21.48,"value":213575.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from  $21.32 to $21.73, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":114103,"source":{"system":"sec-edgar","filing":"0001628908-21-000051","document":"wf-form4_162025209202092.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000051/wf-form4_162025209202092.xml","form_type":"4"}},{"id":2811232,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":91741,"kind":"person","name":"Tutewohl Steve","position":1,"cik":"0001811845","reported_name":"Tutewohl Steve","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-03-04T01:49:05.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Includes restricted stock units granted to Mr. Tutewohl pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 25% annually beginning March 1, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 3s previously filed with the Securities and Exchange Commission."}],"balance_after":124046,"source":{"system":"sec-edgar","filing":"0001628908-21-000034","document":"wf-form4_161482253003982.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000034/wf-form4_161482253003982.xml","form_type":"4"}}]}